Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.

Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Cabel L, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Generali D, Cappelletti MR, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Darrigues L, Reis-Filho JS, Gerratana L, Michiels S, Bidard FC, Pantel K.

Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19. Review.

PMID:
30771872
2.

Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System.

Almici C, Neva A, Skert C, Bruno B, Verardi R, Di Palma A, Bianchetti A, Braga S, Piovani G, Cancelli V, Omedè P, Baeten K, Rotta G, Russo D, Marini M.

Sci Rep. 2019 Jan 14;9(1):87. doi: 10.1038/s41598-018-36442-9.

3.

Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2019 Jan;7(1):12-28. doi: 10.1158/2326-6066.CIR-18-0141. Epub 2018 Nov 6. Erratum in: Cancer Immunol Res. 2019 Apr;7(4):693.

PMID:
30401679
4.

A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges.

Lanuti P, Simeone P, Rotta G, Almici C, Avvisati G, Azzaro R, Bologna G, Budillon A, Di Cerbo M, Di Gennaro E, Di Martino ML, Diodato A, Doretto P, Ercolino E, Falda A, Gregorj C, Leone A, Losa F, Malara N, Marini M, Mastroroberto P, Mollace V, Morelli M, Muggianu E, Musolino G, Neva A, Pierdomenico L, Pinna S, Piovani G, Roca MS, Russo D, Scotti L, Tirindelli MC, Trunzo V, Venturella R, Vitagliano C, Zullo F, Marchisio M, Miscia S.

Sci Rep. 2018 Apr 11;8(1):5823. doi: 10.1038/s41598-018-24234-0.

5.

Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.

Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, Tozzi P, Cattaneo C, Casari S, Skert C, Bocci C, Spina M, Allione B, Verga L, Michieli M, Almici C, Leali PF, Tirelli U, Rossi G.

Bone Marrow Transplant. 2018 Feb;53(2):228-230. doi: 10.1038/bmt.2017.230. Epub 2017 Oct 9. No abstract available.

PMID:
28991244
6.

Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.

Almici C, Skert C, Bruno B, Bianchetti A, Verardi R, Di Palma A, Neva A, Braga S, Piccinelli G, Piovani G, Malagola M, Bernardi S, Giaccone L, Brunello L, Festuccia M, Baeten K, Russo D, Marini M.

Bone Marrow Transplant. 2017 Dec;52(12):1637-1642. doi: 10.1038/bmt.2017.194. Epub 2017 Sep 11.

PMID:
28892085
7.

Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience.

Malagola M, Rambaldi B, Ravizzola G, Cattaneo C, Borlenghi E, Polverelli N, Turra A, Morello E, Skert C, Cancelli V, Cattina F, Giannetta G, Bernardi S, Perucca S, Almici C, Roccaro A, Signorini L, Stellini R, Castelli F, Caruso A, Russo D.

Mediterr J Hematol Infect Dis. 2017 Jun 20;9(1):e2017036. doi: 10.4084/MJHID.2017.036. eCollection 2017.

8.

Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).

Perucca S, Di Palma A, Piccaluga PP, Gemelli C, Zoratti E, Bassi G, Giacopuzzi E, Lojacono A, Borsani G, Tagliafico E, Scupoli MT, Bernardi S, Zanaglio C, Cattina F, Cancelli V, Malagola M, Krampera M, Marini M, Almici C, Ferrari S, Russo D.

PLoS One. 2017 Feb 23;12(2):e0172430. doi: 10.1371/journal.pone.0172430. eCollection 2017.

9.

Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature.

Grisanti S, Antonelli A, Buglione M, Almici C, Foroni C, Sodano M, Triggiani L, Greco D, Palumbo C, Marini M, Magrini SM, Berruti A, Simeone C.

Anticancer Res. 2016 Jun;36(6):2975-81. Review.

PMID:
27272813
10.

Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.

Lanuti P, Rotta G, Almici C, Avvisati G, Budillon A, Doretto P, Malara N, Marini M, Neva A, Simeone P, Di Gennaro E, Leone A, Falda A, Tozzoli R, Gregorj C, Di Cerbo M, Trunzo V, Mollace V, Marchisio M, Miscia S.

Cytometry A. 2016 Mar;89(3):259-70. doi: 10.1002/cyto.a.22730. Epub 2015 Aug 25.

11.

Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease.

Almici C, Skert C, Verardi R, Di Palma A, Bianchetti A, Neva A, Braga S, Malagola M, Turra A, Marini M, Russo D.

Transplantation. 2014 Oct 15;98(7):706-12. doi: 10.1097/TP.0000000000000385.

PMID:
25119132
12.

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.

Grisanti S, Almici C, Consoli F, Buglione M, Verardi R, Bolzoni-Villaret A, Bianchetti A, Ciccarese C, Mangoni M, Ferrari L, Biti G, Marini M, Ferrari VD, Nicolai P, Magrini SM, Berruti A.

PLoS One. 2014 Aug 8;9(8):e103918. doi: 10.1371/journal.pone.0103918. eCollection 2014.

13.

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.

Rossi G, Skert C, Morello E, Almici C, Arcaini L, Basilico C, Cavalli L, Botto B, Castelli A, Pica G, Ripamonti F, Salvi F, Carella AM, Gaidano G, Levis A, Nosari A, Russo D, Vitolo U.

Hematol Oncol. 2015 Sep;33(3):125-32. doi: 10.1002/hon.2148. Epub 2014 May 29.

PMID:
24890497
14.

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S.

Lancet Oncol. 2014 Apr;15(4):406-14. doi: 10.1016/S1470-2045(14)70069-5. Epub 2014 Mar 11.

PMID:
24636208
15.

Stem cell mobilization in HIV seropositive patients with lymphoma.

Re A, Cattaneo C, Skert C, Balsalobre P, Michieli M, Bower M, Ferreri AJ, Hentrich M, Ribera JM, Allione B, Schommers P, Montoto S, Almici C, Ferremi P, Mazzucato M, Gattillo S, Casari S, Spina M, Diez-Martin JL, Tirelli U, Rossi G; Cooperative European Group on AIDS and Tumors.

Haematologica. 2013 Nov;98(11):1762-8. doi: 10.3324/haematol.2013.089052. Epub 2013 Aug 23.

16.

Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.

Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, Bolzoni A, Marini M, Simoncini E, Nicolai P, Biti G, Magrini SM.

Eur J Cancer. 2012 Nov;48(16):3019-26. doi: 10.1016/j.ejca.2012.05.007. Epub 2012 Jun 7.

PMID:
22682019
17.

Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial.

Consoli F, Grisanti S, Amoroso V, Almici C, Verardi R, Marini M, Simoncini E.

Tumori. 2011 Nov-Dec;97(6):737-42. doi: 10.1700/1018.11090.

PMID:
22322840
18.

Circulating tumor cells and cardiac metastasis from esophageal cancer: a case report.

Consoli F, Arcangeli G, Ferrari V, Grisanti S, Almici C, Bordonali T, Simoncini E.

Case Rep Oncol. 2011 May;4(2):299-303. doi: 10.1159/000329021. Epub 2011 May 28.

19.

Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.

Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L, Cassani S, Buglione M, Grisanti S, Almici C, Polli C, Saieva C, Magrini SM, Biti G, Pazzagli M, Orlando C.

Radiother Oncol. 2011 Jun;99(3):356-61. doi: 10.1016/j.radonc.2011.05.062. Epub 2011 Jun 23.

PMID:
21704413
20.

Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.

Almici C, Ferremi P, Lanfranchi A, Ferrari E, Verardi R, Marini M, Rossi G.

Haematologica. 2003 Dec;88(12):1390-5.

21.

A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.

Cattaneo C, Almici C, Borlenghi E, Motta M, Rossi G.

Leukemia. 2003 May;17(5):985-6. No abstract available.

PMID:
12750718
22.

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.

Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, Bonomini S, Lunghi P, Hojden M, Genestreti G, Svaldi M, Coser P, Fattori PP, Sammarelli G, Gazzola GC, Bataille R, Almici C, Caramatti C, Mangoni L, Rizzoli V.

Blood. 2003 Jul 15;102(2):638-45. Epub 2003 Mar 20.

23.

Reconstitution of T-cell receptor repertoire diversity following non-myeloablative allogeneic stem cell transplantation in an acute myeloid leukemia patient.

Almici C, Imberti L, Lanfranchi A, Verardi R, Bellinzoni M, Berta S, Izzi T.

Haematologica. 2002 Oct;87(10):ECR31. No abstract available.

PMID:
12368174
24.

Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?

Pagano L, Pulsoni A, Tosti ME, Mele A, Mele L, Corvatta L, Miraglia E, Almici C, Manna A, Del Poeta G, Lanza F, Masini L, Recchia A, Equitani F, Leone G, Mandelli F; Italian GIMEMA Group (Gruppo Italiano Malattie Ematologiche dell'Adulto).

Hematol J. 2000;1(5):329-32.

PMID:
11920210
25.

Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group.

Pagano L, Pulsoni A, Mele L, Tosti ME, Cerri R, Visani G, Melillo L, Candoni A, Clavio M, Nosari A, Petti MC, Martino B, Mele A, Levis A, Allione B, Almici C, Equitani F, Leone G, Mandelli F; Gruppo Italiano Malattie Ematologiche dell'Adults.

Ann Oncol. 2001 Feb;12(2):203-7.

PMID:
11300325
26.

The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase.

Cesana C, Giachetti R, Almici C, Garau D, Mangoni L, Pesci A, Carlo-Stella C.

Haematologica. 1998 Mar;83(3):276-9. No abstract available.

27.

High-dose therapy in acute leukemia.

Carlo-Stella C, Mangoni L, Caramatti C, Almici C, Rizzoli V.

Leuk Lymphoma. 1997 Dec;26 Suppl 1:61-7.

PMID:
9570681
28.

Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood.

Almici C, Carlo-Stella C, Wagner JE, Mangoni L, Garau D, Rizzoli V.

Leukemia. 1997 Dec;11(12):2143-9.

PMID:
9447833
29.

Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.

Almici C, Carlo-Stella C, Wagner JE, Mangoni L, Garau D, Re A, Giachetti R, Cesana C, Rizzoli V.

Bone Marrow Transplant. 1997 Jun;19(11):1079-84.

30.

In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.

Cesana C, Carlo-Stella C, Mangoni L, Regazzi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V.

Stem Cells. 1997;15(3):207-13.

31.

Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.

Carlo-Stella C, Dotti G, Mangoni L, Regazzi E, Garau D, Bonati A, Almici C, Sammarelli G, Savoldo B, Rizzo MT, Rizzoli V.

Blood. 1996 Oct 15;88(8):3091-100.

32.

Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping.

Almici C, Carlo-Stella C, Rizzoli V, Wagner JE.

Blood. 1996 Aug 15;88(4):1520-1. No abstract available.

33.

Response to cyclosporin A and recombinant human erythropoietin in a case of B cell chronic lymphocytic leukemia and pure red cell aplasia.

Cesana C, Carlo-Stella C, Mangoni L, Almici C, Giachetti R, Zappa M, Rizzoli V.

Leukemia. 1996 Aug;10(8):1400-1. No abstract available.

PMID:
8709652
34.

Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.

Carlo-Stella C, Regazzi E, Garau D, Mangoni L, Rizzo MT, Bonati A, Dotti G, Almici C, Rizzoli V.

Br J Haematol. 1996 Jun;93(3):551-7.

PMID:
8652372
35.

BCL2 oncogene protein expression in human hematopoietic precursors during fetal life.

Bonati A, Albertini R, Garau D, Pinelli S, Lunghi P, Almici C, Carlo-Stella C, Rizzoli V, Dall'Aglio P.

Exp Hematol. 1996 Feb;24(3):459-65.

PMID:
8599976
36.

Density separation and cryopreservation of umbilical cord blood cells: evaluation of recovery in short-and long-term cultures.

Almici C, Carlo-Stella C, Wagner JE, Rizzoli V.

Acta Haematol. 1996;95(3-4):171-5.

PMID:
8677738
37.

Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application.

Almici C, Carlo-Stella C, Wagner JE, Rizzoli V.

Haematologica. 1995 Sep-Oct;80(5):473-9. Review.

38.

Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.

Almici C, Carlo-Stella C, Mangoni L, Garau D, Cottafavi L, Ventura A, Armanetti M, Wagner JE, Rizzoli V.

Stem Cells. 1995 Sep;13(5):533-40.

PMID:
8528103
39.

Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice.

Wagner JE, Collins D, Fuller S, Schain LR, Berson AE, Almici C, Hall MA, Chen KE, Okarma TB, Lebkowski JS.

Blood. 1995 Jul 15;86(2):512-23.

40.

Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.

Almici C, Manoni L, Carlo-Stella C, Garau D, Cottafavi L, Rizzoli V.

Bone Marrow Transplant. 1995 Jul;16(1):95-101.

PMID:
7581136
41.

Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.

Dotti G, Stella CC, Mangoni L, Cottafavi L, Caramatti C, Almici C, Rizzoli V.

Haematologica. 1995 Mar-Apr;80(2):142-5.

42.

Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.

Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Cottafavi L, Dotti GP, Rizzoli V.

Bone Marrow Transplant. 1994 Sep;14(3):425-32.

PMID:
7994267
43.
44.

Selection of Philadelphia-negative progenitors from chronic myelogenous leukemia.

Carlo-Stella C, Mangoni L, Piovani G, Garau D, Dotti GP, Almici C, Rizzoli V.

Bone Marrow Transplant. 1994;14 Suppl 3:S45-8. No abstract available.

PMID:
7535153
45.

Biological and chemical selection of Ph-negative clones.

Carlo-Stella C, Mangoni L, Piovani G, Garau D, Almici C, Rizzoli V.

Stem Cells. 1993 Oct;11 Suppl 3:77-82.

PMID:
8298479
46.

Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.

Rizzoli V, Mangoni L, Almici C, Caramatti C, Dotti GP, Carlo-Stella C.

Stem Cells. 1993 Oct;11 Suppl 3:25-30.

PMID:
8298474
47.

Counterflow centrifugal elutriation: present and future.

Almici C, Carlo-Stella C, Donnenberg AD, Rizzoli V.

Bone Marrow Transplant. 1993 Aug;12(2):105-8. Review.

PMID:
8401353
48.

Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.

Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.

Stem Cells. 1993 Jul;11 Suppl 2:170-4.

PMID:
7691323
49.

Adherence of human monocytes to haemodialysis membranes.

David S, Tetta C, Camussi G, Canino F, Almici C, Rizzoli V, Cambi V.

Nephrol Dial Transplant. 1993;8(11):1223-7.

PMID:
8302460
50.

Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.

Rizzoli V, Mangoni L, Piovani G, Garau D, Caramatti C, Almici C, Carlo-Stella C.

Leuk Lymphoma. 1993;11 Suppl 1:109-12.

PMID:
8251884

Supplemental Content

Loading ...
Support Center